Indeed, one of the most commonly used drugs for primary and secondary prevention of BC is tamoxifen, an antagonist of the estrogen receptor (ER) which is encoded by ESR1, a known target of a BC risk locus [1]. The gene discussed is ESR1; the disease is breast cancer.